info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

Nanoparticle-Based Drug Delivery Systems Market By Drug Type (Chemotherapy Drugs, Gene Therapy Drugs, Protein and Peptide Drugs); By Technology Type (Liposomes, Polymeric Nanoparticles, Solid Lipid Nanoparticles); By Application (Cancer Treatment, Neurological Disorders, Infectious Diseases); By End User (Children’s Hospitals, General Hospitals, Research Institutions, Pharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction and Strategic Context

The Global Nanoparticle-Based Drug Delivery Systems Market is set to grow at a 12.6% CAGR, expanding from USD 4.2 billion in 2024 to USD 8.6 billion by 2030<... Read More

Published Date: SEP-2025 | No Of Pages:170 | $ 4485

Glaucoma Drainage Devices Market By Product Type (Valved Implants, Non-Valved Implants); By Indication (Open-Angle Glaucoma, Angle-Closure Glaucoma, Congenital & Pediatric Glaucoma); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Eye Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Glaucoma Drainage Devices (GDDs) Market strengthening through ophthalmic devices, glaucoma treatment devices, medical technology, healthcare equip... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Gingival Recession Market By Product Type (Soft Tissue Grafts, Regenerative Biomaterials, Dental Membranes, Growth Factors); By Treatment Approach (Surgical Flap Procedures, Connective Tissue Grafts, Guided Tissue Regeneration); By End User (Private Clinics, Hospitals, Academic Institutions, Specialty Periodontal Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gingival Recession Market is expected to grow steadily, with an valuation of 1.9 billion USD in 2024 and projected to reach 2.8 billion USD by 2030 . This reflects a Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Needle-Free Drug Delivery Devices Market By Device Type (Jet Injectors, Transdermal Patches, Inhaler-Based Systems, Microneedle-Based Systems); By Application (Vaccination, Pain Management, Insulin Delivery, Cosmetic Dermatology, Oncology & Autoimmune Disorders); By End User (Hospitals & Clinics, Home Care Settings, Ambulatory Surgical Centers, Cosmetic & Dermatology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Needle-Free Drug Delivery Devices Market propelled by needle-free injectors, transdermal therapeutic systems, biopharmaceutical injection devices, Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Oligonucleotide Therapeutics Market By Drug Type (Antisense Oligonucleotides, Small Interfering RNAs, Aptamers, Others); By Application (Rare Genetic Disorders, Oncology, Metabolic/Liver Diseases, Infectious Diseases, Ophthalmology); By Route of Administration (Subcutaneous, Intrathecal, Intravenous, Others); By End User (Academic Hospitals, Specialty Clinics, Outpatient Centers, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oligonucleotide Therapeutics Market is expected to witness a strong CAGR of 14.6%, valued at USD 8.1 billion in 2024 and projected to surpass USD 18.4 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Animal Hormones Market By Product Type (Growth Promoters, Reproductive Hormones, Metabolic Hormones); By Species (Cattle, Swine, Poultry, Companion Animals, Aquaculture); By Route of Administration (Injectables, Implants, Oral); By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online, Direct-to-Farm); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Animal Hormones Market will witness a steady CAGR of 5.9%, valued at around USD 2.9 billion in 2024, and is expected to reach nearly USD 4.1 billi... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Adipose-derived Stem Cell Market By Cell Type (Autologous, Allogenic); By Application (Regenerative Medicine, Aesthetic Medicine, Wound Healing & Tissue Repair, Drug Discovery & Research); By End User (Hospitals & Specialty Clinics, Cosmetic & Aesthetic Clinics, Research Institutions, Biotech & Cell Therapy Developers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adipose-Derived Stem Cell Market grows at 9.6% CAGR, rising from USD 1.6 billion in 2024 to USD 2.8 billion by 2030, driven by adipose stem cells<... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Presbyopia Correction Device Market By Product Type (Intraocular Lenses, Corneal Inlays, Light Adjustable Lenses, Corneal Refractive Procedures); By Technology (Monovision Correction, Multifocal & EDOF Platforms, Wavefront-Guided Systems); By End User (Hospitals, Specialty Eye Clinics, Ambulatory Surgical Centers, Retail & Optometry Chains); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Presbyopia Correction Device Market valued at USD 5.1 billion in 2024 and projected to reach USD 7.8 billion by 2030 at 7.3% CAGR, reflecting glob... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Veterinary Antihistamines Market By Product Type (H1 Antagonists, H2 Antagonists, Combination Antihistamines); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Veterinary Antihistamines Market projected to reach USD 1.07 billion by 2030 from USD 720 million in 2024 at expanding 5.8% CAGR, driven by veteri... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Urology Disposable Market By Product Type (Urinary Catheters, Drainage Bags, Ureteral Stents, Guidewires & Access Sheaths, Irrigation Sets); By Application (Urinary Incontinence, BPH, Urinary Retention, Urolithiasis, Spinal/Neurogenic Disorders); By End User (Hospitals, Urology Clinics, Ambulatory Surgical Centers, Home Healthcare, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Urology Disposable Market fueled by medical disposables, urology devices, hospital consumables, infection prevention technology, ... Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Familial Adenomatous Polyposis Treatment Market By Treatment Type (Pharmacologic Therapy, Surgical Intervention, Gene Therapy); By End User (Hospitals, Specialty Clinics, Research Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Familial Adenomatous Polyposis Treatment Market is poised to grow at a robust CAGR of 8.2%, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billio... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Collagen Filler Market By Product Type (Animal-Based Collagen Fillers, Synthetic/Recombinant Collagen Fillers); By Application (Facial Aesthetics, Scar Correction, Lip Enhancement, Hand Rejuvenation, Post-Surgical Reconstruction); By End User (Dermatology Clinics, Plastic Surgery Centers, Med-Spas, Wellness Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Collagen Filler Market valued at USD 1.4 billion in 2024 and projected to reach USD 2.3 billion by 2030 at 8.6% CAGR, driven by collagen filler ma... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Long Acting Drugs Market By Drug Type (Long Acting Injectables, Extended-Release Oral Tablets, Implants and Inserts, Transdermal Patches and Films); By Therapeutic Application (Psychiatry & Neurology, Infectious Diseases, Oncology, Endocrinology & Diabetes, Women’s Health, Pain & Addiction); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics & Public Health Programs, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Long Acting Drugs Market valued at $64.3 billion in 2024 and projected to reach $96.2 billion by 2030 at 6.9% CAGR, highlighting injectable drug f... Read More

Published Date: JAN-2026 | No Of Pages:177 | $ 4485

Ophthalmic Disposables Market By Product Type (Surgical Disposables, Diagnostic Disposables, General Ophthalmic Consumables); By Application (Surgery, Diagnostics, Routine Eye Examinations); By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmic Disposables Market is valued at USD 3.2 billion in 2024 and projected to reach USD 4.4 billion by 2030 at 5.6% CAGR, driven by eye... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Recurrent Pericarditis Market by Treatment Type (Biologic Therapies, NSAIDs, Colchicine, Corticosteroids, Surgical Interventions); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Recurrent Pericarditis Market will expand steadily at a CAGR of 6.5%, reaching $2.1 billion by 2030 from $1.2 billion in 2024, supported by cardia... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Postoperative Pain Management Market By Product Type (Non-Opioid Analgesics, Opioid Analgesics, Local Anesthetics, Adjuvant Therapies, Devices, Digital Solutions); By Route of Administration (Oral, Intravenous, Regional, Transdermal, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postoperative Pain Management Market is set to expand at a CAGR of 6.1%, with a market value of USD 13.2 billion in 2024, projected to reach USD 18.8 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Bladder Cancer Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Intravesical Therapy, Combination Therapy); By Disease Stage (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer, Metastatic Bladder Cancer); By Route of Administration (Intravenous, Oral, Intravesical); By End User (Hospitals and Cancer Centers, Specialty Urology Clinics, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bladder Cancer Therapeutics Market will witness steady expansion at a CAGR of 7.6%, valued at USD 4.2 billion in 2024 and projected to reach USD 6.52 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Antibiotic-Coated Surgical Implant Drug Market By Implant Type (Orthopedic Implants, Cardiovascular Implants, Dental Implants, Neurosurgical & Spinal Implants); By Coating Agent (Gentamicin, Vancomycin, Dual-Antibiotic/Polymeric Coatings, Silver & AMPs); By End User (Hospitals & Trauma Centers, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antibiotic-Coated Surgical Implant Drug Market valued at USD 4.1 billion in 2024 and projected to reach USD 6.1 billion by 2030 at 6.8% CAGR, highlighting... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Topical Corticosteroids Market By Product Type (Low-Potency, Medium-Potency, High-Potency); By Formulation (Creams, Ointments, Sprays, Foams, Liposome-Based); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Supermarkets); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Topical Corticosteroids Market is estimated at USD 8.7 billion in 2024 and is projected to reach USD 12.6 billion by 2030, expanding at a CAGR of ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Migraine Nasal Spray Market By Product Type (Branded, Generic); By Drug Class (Triptans, Gepants, Ditans); By Route of Administration (Nasal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By End User (Hospitals, Specialty Clinics, Adults, Adolescents, Geriatric); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Migraine Nasal Spray Market valued at $795 million in 2024 and projected to reach $1.46 billion by 2030 at 10.6% CAGR, driven by migraine treatmen... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Veterinary Corticosteroids Market By Product Type (Dexamethasone, Prednisone, Hydrocortisone, Methylprednisolone, Prednisolone); By Route of Administration (Oral, Injectable, Topical, Inhalable); By Animal Type (Companion Animals, Livestock, Equine); By Distribution Channel (Veterinary Hospitals & Clinics, Retail Veterinary Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Veterinary Corticosteroids Market expanding at 5.6% CAGR, driven by market growth, veterinary corticosteroids, market size, indus... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Dexamethasone Market By Product Type (Injectable, Oral Tablets, Ophthalmic, Topical); By Route of Administration (Oral, Intravenous, Intramuscular, Intraocular, Topical); By Application (Oncology Support, Inflammatory & Autoimmune Diseases, Respiratory Conditions, Allergic Reactions, COVID-19 & Critical Care); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dexamethasone Market will witness a CAGR of 6.5%, valued at USD 2.8 billion in 2024 and expected to reach USD 4.1 billion by 2030, supported by ph... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Pediatric Medical Devices Market By Product Type (Diagnostic Devices, Therapeutic Devices, Surgical Instruments, Assistive & Monitoring Equipment); By Application (Cardiology, Neonatology, Orthopedics, Oncology, Respiratory Disorders, Endocrinology); By End User (Children’s Hospitals, General Hospitals, Ambulatory Surgical Centers, Homecare & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Medical Devices Market supported by pediatric healthcare devices, diagnostic monitoring systems, neonatal ICU equipment, medical technol... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

At-Home Molecular Testing Market By Test Type (Infectious Disease Testing, Oncology Monitoring, Genetic Screening, Women’s Health); By Technology (Isothermal Amplification, CRISPR Diagnostics, Real-Time PCR, Microfluidic Platforms); By Sample Type (Nasal Swab, Saliva, Capillary Blood); By Distribution Channel (Retail Pharmacies, Online Platforms, Telehealth Networks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global At-Home Molecular Testing Market will grow at a strong CAGR of 11.8%, valued at USD 3.6 billion in 2024, and expected to reach USD 7.1 billion by 2030, ac... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Cetuximab Market By Indication (Metastatic Colorectal Cancer, Head & Neck Squamous Cell Carcinoma); By Route of Administration (Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cetuximab Market will expand at an estimated CAGR of 5.6%, rising from a value of USD 1.45 billion in 2024 to nearly USD 2.01 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Phentermine Hydrochloride Market By Product Type (Tablets, Capsules, Orally Disintegrating Tablets); By Route of Administration (Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Phentermine Hydrochloride Market is projected to grow at a CAGR of 4.6%, valued at $520 million in 2024, expected to reach $682 million by 2030, driven by... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Plastic Vials Market By Material Type (Polypropylene, Polyethylene, Polyethylene Terephthalate, Cyclic Olefin Polymer, Others); By Capacity (Less than 5 mL, 5–20 mL, Above 20 mL); By End Use (Pharmaceuticals, Diagnostics, Nutraceuticals & Personal Care, Public Health & NGO Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plastic Vials Market is projected to grow at a CAGR of 5.6%, with an estimated value of USD 2.7 billion in 2024, expected to reach around USD 3.9 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485

Smart Pill Boxes Market By Product Type (Automated Dispensers, Manual Smart Boxes); By Connectivity (Bluetooth-Enabled, Wi-Fi / Cellular-Connected); By End User (Home Healthcare, Hospitals & Clinics, Long-Term Care Facilities, Pharmacies); By Distribution Channel (Online Retailers, Hospitals & Clinics, Third-Party Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Smart Pill Boxes Market is projected to expand steadily between 2024 and 2030, growing at a CAGR of 8.1%. The market is valued at approximately USD 1.6 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Giant Cell Arteritis Market By Therapy Type (Corticosteroids, Biologics, Supportive Therapies); By Route of Administration (Oral, Injectable [Subcutaneous, Intravenous]); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Cell Arteritis (GCA) Market will witness steady expansion, valued at USD 1.3 billion in 2024 and projected to reach USD 2.1 billion by 2030, growing at a CAG... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Uro-Gynaecological Surgical Devices Market By Product Type (Surgical Meshes, Slings, Laparoscopic Instruments, Robotic Systems, Energy Devices, Ancillary Tools); By Application (Pelvic Organ Prolapse Repair, Urinary Incontinence, Hysterectomy, Uro-gynaecological Cancer Surgery); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Uro-Gynaecological Surgical Devices Market highlighting pelvic floor repair devices, urogynecology surgery tools, surgical implants, healthcare de... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Plant-based Vaccines Market By Vaccine Type (Prophylactic Vaccines, Therapeutic Vaccines); By Target Indication (Influenza, COVID-19, HPV, Zika Virus, Others); By Plant System (Tobacco, Maize, Potato, Tomato, Lettuce); By End User (Public Health Agencies, Hospitals & Clinics, Academic & Research Institutions, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Plant-Based Vaccines Market is fueled by plant biotechnology, molecular farming vaccines, recombinant protein technology, biopharmaceutical innova... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Giant Papillary Conjunctivitis Market By Treatment Type (Antihistamines & Mast Cell Stabilizers, Corticosteroids, Immunomodulators, Lubricants & Supportive Care); By Route of Administration (Topical Eye Drops, Ophthalmic Inserts, Systemic Therapy); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Giant Papillary Conjunctivitis (GPC) Market is projected to grow at a CAGR of 6.5% between 2024 and 2030, climbing from an estimated value of USD 1.26 billion in 2024 to a... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Giant Axonal Neuropathy Market By Treatment Type (Gene Therapy, Antisense Oligonucleotides, Supportive & Symptomatic Care); By Route of Administration (Intrathecal, Intravenous, Oral & Others); By End User (Academic & Research Hospitals, Specialty Neurology Clinics, Pediatric Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Giant Axonal Neuropathy (GAN) Market is projected to grow at a CAGR of 19.8% between 2024 and 2030, with an estimated market size of USD 78.2 million in 2024 and reaching ... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Gestational Diabetes Market By Treatment Type (Insulin Therapy, Oral Hypoglycemic Agents, Lifestyle & Nutritional Management); By Diagnostic Approach (OGTT & GCT, HbA1c Testing, Continuous Glucose Monitoring); By End User (Hospitals & Maternity Clinics, Diagnostic Laboratories, Digital Health Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gestational Diabetes Market is projected to grow at a steady CAGR of 6.7%, valued at USD 2.8 billion in 2024 and anticipated to reach USD 4.1 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Gene Therapy in Ophthalmology Market By Therapy Type (Gene Augmentation, Gene Editing, RNA-based Therapy); By Disease Indication (Leber Congenital Amaurosis, Retinitis Pigmentosa, Stargardt Disease, Choroideremia, X-linked Retinoschisis, Wet AMD, Diabetic Macular Edema); By Delivery Method (Subretinal, Suprachoroidal, Intravitreal); By End User (Academic Medical Centers, Specialty Retina Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Gene Therapy In Ophthalmology Market will witness a robust CAGR of 26.5% , valued at USD 1.42 billion in 2024 , and expe... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Frontotemporal Dementia Market By Product Type (Therapeutics, Diagnostics); By Therapeutic Approach (Tau-Targeted Therapies, TDP-43 Modulators, Symptomatic Management); By End User (Hospitals & Memory Clinics, Specialty Neurology Centers, Research Institutes, Home & Outpatient Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Frontotemporal Dementia Market valued at USD 1.9 billion in 2024 and expected to reach USD 2.9 billion by 2030 at 6.8%, CAGR, driven by clinical t... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Excessive Daytime Sleepiness Market By Drug Class (Stimulants, Wakefulness-Promoting Agents, Non-Stimulant Therapies, Digital Therapeutics); By Underlying Condition (Obstructive Sleep Apnea, Narcolepsy, Idiopathic Hypersomnia, Shift Work Sleep Disorder); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Telehealth Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Excessive Daytime Sleepiness Market is anticipated to expand at a CAGR of 8.1%, estimated at $4.3 billion in 2024 and projected to reach $6.8 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Erosive Hand Osteoarthritis Market By Treatment Type (Pharmacological Treatment, Surgical Treatment, Non-Pharmacological Treatment); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Erosive Hand Osteoarthritis Market is poised to grow at a CAGR of 6.3% , reaching an estimated value of USD 1.12 billion by 2030 , up from USD 780... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Epithelioid Sarcoma Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Surgery, Radiation Therapy); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Epithelioid Sarcoma Treatment Market is projected to reach USD 1.36 billion by 2030 , up from an estimated USD 820 million in 2024 , expanding at a Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Emphysema Market By Treatment Type (Inhaled Medications, Biologics, Surgical & Device-Based Interventions, Pulmonary Rehabilitation & Oxygen Therapy); By Route of Administration (Inhalation, Oral, Injectable/Biologic); By End User (Hospitals, Retail Pharmacies, Homecare Providers, Payers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Emphysema Market is projected to grow steadily between 2024 and 2030, valued at USD 6.8 billion in 2024 and forecasted to reach USD 9.7 billion by 2030 , ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Ebola Fever Therapeutics Market By Product Type (Monoclonal Antibody Therapies, Antiviral Agents, RNA-Based Therapeutics, Supportive Therapies & Immunomodulators); By Route of Administration (Intravenous, Oral, Intramuscular/Subcutaneous); By Distribution Channel (Government & Public Health Procurement, NGOs & Humanitarian Agencies, Hospital Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Ebola Fever Therapeutics Market is projected to expand steadily at a CAGR of 6.9% , growing from an estimated USD 1.02 billion in... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Drug Infusion System Market By Product Type (Volumetric Pumps, Syringe Pumps, Elastomeric Pumps, Insulin Pumps, Others); By Application (Oncology, Diabetes, Pain Management, Parenteral Nutrition, Others); By End User (Hospitals, Homecare, Ambulatory Surgical Centers, Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Infusion System Market is projected to grow at a CAGR of 8.3%, with a value of USD 14.2 billion in 2024 and estimated USD 22.8 billion by 2030, fuele... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Diverticulitis Market By Treatment Type (Medical, Surgical); By Product Type (Pharmaceuticals, Nutritional Therapies, Surgical Devices, Digital Monitoring Tools); By Disease Type (Uncomplicated, Complicated); By End User (Hospitals, Gastroenterology Clinics, Ambulatory Surgical Centers, Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diverticulitis Market expanding from USD 4.1 billion in 2024 to USD 6.0 billion by 2030 at a CAGR of 6.5%, reflecting market growth, Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Diarrhea Therapeutics Market By Drug Class (Oral Rehydration Salts, Anti-Motility Agents, Antibiotics, Probiotics, Zinc Supplements); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diarrhea Therapeutics Market will witness a steady CAGR of 5.8% , valued at USD 9.6 billion in 2024 and expected to reac... Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Continuous Bioprocessing Market By Product Type (Upstream Bioreactors, Continuous Chromatography, TFF Systems, PAT, Single-Use Systems, Automation Software); By Application (Clinical Production, Commercial Manufacturing, R&D, Process Development); By End User (Pharmaceutical Companies, Biotech Startups, CDMOs, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Continuous Bioprocessing Market expanding from USD 4.3 billion in 2024 to USD 10.2 billion by 2030, with a CAGR of 15.1%, fueled by continuous bio... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Congenital Adrenal Hyperplasia Treatment Market By Drug Type (Glucocorticoids, Mineralocorticoids, Steroidogenesis Inhibitors, CRF1 Receptor Antagonists); By Route of Administration (Oral, Injectable, Transdermal); By Age Group (Pediatric, Adolescent, Adult); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congenital Adrenal Hyperplasia (CAH) Treatment Market will register growth at a CAGR of 6.8%, expanding from USD 472 million in 2024 to USD 703 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Clinically Isolated Syndrome Market By Drug Class (Injectables, Oral Therapies, Monoclonal Antibodies); By Diagnostic Tool (MRI, CSF Analysis, Optical Coherence Tomography, Evoked Potentials); By Patient Type (Adults, Pediatric Onset, High-Risk Patients); By End User (Neurology Clinics, Imaging Centers, Hospitals, Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Clinically Isolated Syndrome (CIS) Market is projected to grow at a steady CAGR of 6.5% , reaching an estimated value of $2.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Clear Cell Ovarian Cancer Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Surgical Intervention); By Disease Stage (Stage I–II, Stage III–IV); By End User (Academic & Research Hospitals, Cancer Specialty Centers, General Hospitals, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Clear Cell Ovarian Cancer Market is projected to expand at a CAGR of 6.8%, reaching approximately USD 1.9 billion by 2030, up from an estimated USD 1.3 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Chronic Traumatic Encephalopathy Market By Diagnostic Type (Neuroimaging, Blood Biomarkers, Neurocognitive Tools); By Intervention Type (Symptom Management Drugs, Neuroprotective Therapies, Behavioral & Cognitive Therapy); By End User (Neurology Clinics, Sports Medicine Institutions, Veteran Health Systems, Academic Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Traumatic Encephalopathy (CTE) Market is forecast to grow from USD 1.2 billion in 2024 to USD 2.1 billion by 2030, registering a CAGR of 9.1%, sup... Read More

Published Date: JAN-2026 | No Of Pages:192 | $ 4485

Chronic Myelomonocytic Leukemia Market By Treatment Type (Hypomethylating Agents, Targeted Therapies, Stem Cell Transplantation, Supportive Care); By Route of Administration (Injectable, Oral); By End User (Academic Medical Centers, Community Oncology Clinics, Transplant Centers, Specialized Hematology Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Myelomonocytic Leukemia (CMML) Market was valued at approximately USD 720 Million in 2024 and is projected to surpass USD 1.1 Billion by 2030, expanding at aRead More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Chronic Idiopathic Urticaria Treatment Market By Drug Class (Antihistamines, Monoclonal Antibodies, Leukotriene Receptor Antagonists, Immunosuppressants); By Route of Administration (Oral, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Idiopathic Urticaria Treatment Market is anticipated to grow from USD 4.8 billion in 2024 to around USD 7.6 billion by 2030, achieving a CAGR of 7.9% (2024... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cervical Intraepithelial Neoplasia Market By CIN Grade (CIN I, CIN II, CIN III); By Diagnostic Method (Pap Smear, HPV Testing, Colposcopy, Biomarker Triage); By Treatment (Cryotherapy, LEEP, Cold Knife Conization, Immunotherapy); By End User (Hospitals, Specialty Clinics, Diagnostic Labs, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cervical Intraepithelial Neoplasia (CIN) Market will witness a steady CAGR of 6.8%, valued at USD 1.32 billion in 2024, and projected to ... Read More

Published Date: JAN-2026 | No Of Pages:185 | $ 4485

Cerebrotendinous Xanthomatosis Market By Treatment Type (Chenodeoxycholic Acid, Adjunctive Therapies, Pipeline/Investigational Drugs); By Route of Administration (Oral, Future-IV/Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cerebrotendinous Xanthomatosis Market is projected to grow at a CAGR of 6.7% , with a market value of USD 223.0<... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Cell Migration and Cell Invasion Assay Market By Assay Type (2D Assays, 3D Assays); By Application (Cancer Research, Stem Cell & Regenerative Medicine, Immunology, Wound Healing & Tissue Engineering, Neurology & Developmental Biology); By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Migration And Cell Invasion Assay Market is projected to reach $1.1 billion by 2030 , up from $ 680.0 million in 2024 , growing at a CAGR of 8.4% dur... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Carotid Artery Stents Market By Type (Self-Expanding Stents, Balloon-Expandable Stents); By Material (Nitinol, Stainless Steel, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Carotid Artery Stents Market will witness a steady CAGR of 7.1% , valued at USD 1.18 billion in 2024 , and projected to reach nearly USD 1.78 bill... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Cardiovascular Calcification Market By Product Type (Imaging Systems, Atherectomy Devices, Drug-Eluting Stents, Transcatheter Heart Valves); By Application (Coronary Artery Disease, Aortic Valve Stenosis, Peripheral Artery Disease, CKD-Related Vascular Calcification); By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Clinics, Dialysis & Nephrology Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Calcification Market is projected to rise at a CAGR of 6.5%, valued at USD 2.9 billion in 2024 and expected to reach USD 4.3 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Cannabis Use Disorder Market By Treatment Type (Pharmacological, Non-Pharmacological); By Delivery Channel (Outpatient Clinics, Digital Therapeutics, Primary Care, University Programs); By Patient Demographics (Age Group, Gender); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Use Disorder Market is projected to reach $3.1 billion in 2030 , up from an estimated $1.8 billion in 2024 , growing at a CAGR of 9.4% during the... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Bronchiolitis Obliterans Syndrome Market By Treatment Type (Immunosuppressants, Corticosteroids, Macrolides, Antifibrotics); By Application (Lung Transplant-Associated BOS, HSCT-Associated BOS); By Route of Administration (Oral, Inhalation, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchiolitis Obliterans Syndrome Market will grow at a CAGR of 6.5% , valued at nearly USD 1.42 billion in 2024 and projected to reach around USD 2.08 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Bronchial Spasm Market By Drug Type (Short-acting β2-Agonists, Long-acting Bronchodilators, Anticholinergics, Leukotriene Receptor Antagonists); By Route of Administration (Inhaled [MDI, DPI], Nebulized, Oral, Others); By End User (Hospitals, Specialty Clinics, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchial Spasm Market is projected to grow at a steady CAGR of 6.4% , increasing from a market value of USD 1.42 billion in 2024 to USD 2.07 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Blastomycosis Treatment Market By Treatment Type (Antifungal Drugs, Surgical Intervention); By End-User (Hospitals, Outpatient Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Blastomycosis Treatment Market is valued at USD 3.4 billion in 2024 and is expected to reach USD 5.7 billion by 2030, growing at a Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

BK Virus Infection Market By Product Type (Diagnostic Tests, Therapeutic Solutions); By Application (Organ Transplants, Immunocompromised Patients); By End-User (Hospitals & Transplant Centers, Diagnostic Laboratories, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global BK Virus Infection Market is valued at approximately USD 500 million in 2024, projected to reach USD 750 million by 2030, progressing at a CAGR of 7% from 2024 to ... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Bacterial Vaginosis Treatment Market By Treatment Type (Antibiotic Treatments, Probiotics-based Therapy, Topical Treatments, Oral Medications); By End-User (Hospitals & Clinics, Retail Pharmacies, Online Platforms, Diagnostic Imaging Centers, Gynecologists & General Practitioners); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bacterial Vaginosis Treatment Market will witness steady growth, with a projected CAGR of 5.5% from 2024 to 2030. The market was valued at approximately USD 1.3 bi... Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Asperger Syndrome Treatment Market By Treatment Type (Behavioral Therapy, Occupational & Speech Therapy, Pharmacological Treatment, Digital Therapeutics & Assistive Technologies); By Age Group (Children, Adolescents, Adults); By End User (Specialty Clinics, Hospitals & Diagnostic Centers, Educational Institutions, Home-Based & Remote Therapy Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Asperger Syndrome Treatment Market expanding with 8.9% CAGR and reaching approximately USD 3.7 billion by 2030 from USD 2.1 billion in 2024, led by Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Arteriovenous Malformations Market By Treatment Type (Embolization, Stereotactic Radiosurgery, Microsurgical Resection, Pharmacological Management); By Diagnostic Modality (DSA, MRI/MRA, CT Angiography, Functional Imaging); By Anatomical Location (Cerebral AVMs, Spinal AVMs, Peripheral AVMs, Visceral AVMs); By End User (Tertiary Hospitals, Academic Centers, General Hospitals, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Arteriovenous Malformations (AVM) Market is projected to grow at a 6.4% CAGR, rising from USD 2.7 billion in 2024 to USD 4.1 billion by 2030, driven by neurovascular treat... Read More

Published Date: JAN-2026 | No Of Pages:170 | $ 4485

Aplastic Anemia Treatment Market By Treatment Type (Immunosuppressive Therapy, Bone Marrow Transplantation, Supportive Care, Others); By Drug Class (Anti-thymocyte Globulin [ATG], Cyclosporine, Eltrombopag, Others); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aplastic Anemia Treatment Market is projected to grow at a robust 8.9% CAGR, rising from USD 1.32 billion in 2024 to nearly USD 2.19 billion by 2030, driv... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485

Ankle Fusion Nail Market By Product Type (Standard Ankle Fusion Nails, Modular/Customized Fusion Nails); By Surgical Approach (Retrograde Insertion, Antegrade Insertion); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Orthopedic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ankle Fusion Nail Market is projected to grow at a CAGR of 6.5%, rising from USD 420 million in 2024 to USD 650 million by 2030, driven by increasing orth... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Transcatheter Edge-to-Edge Repair Devices Market By Device Type (Mitral, Tricuspid, Other Valve Devices); By Application (Mitral Regurgitation, Tricuspid Regurgitation, Others); By End User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Transcatheter Edge-To-Edge Repair Devices Market is positioned for remarkable expansion, with a projected CAGR of 15.6%, valued at USD 1.7 billion in 2024 and set to reach... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Stuttering Treatment Market By Treatment Type (Speech Therapy, Digital & App-Based Therapy, Pharmacological Treatment, Assistive Devices & Wearables); By Age Group (Children, Adolescents, Adults); By End User (Speech & Language Clinics, Hospitals & Rehabilitation Centers, Schools & Educational Institutions, Direct-to-Consumer Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Stuttering Treatment Market is forecast to grow at CAGR of 6.8%, increasing from USD 3.1 billion in 2024 to nearly USD 4.6 billion by 2030, fueled by Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Lipase Inhibitors Obesity Drugs Market By Product Type (Prescription Drugs, Over-the-Counter); By Route of Administration (Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lipase Inhibitors Obesity Drugs Market will expand at 5.9% CAGR, rising from USD 1.46 billion in 2024 to USD 2.07 billion by 2030, driven by rising obesity prevalence and ... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Radiodermatitis Market By Product Type (Topical Agents, Oral Medications, Dressings and Hydrogel Pads, Barrier Films and Sprays, Radioprotective Drugs); By Stage of Severity (Grade 1, Grade 2, Grade 3+); By End User (Hospitals, Specialty Dermatology Clinics, Ambulatory Radiation Centers, Retail Pharmacies & Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radiodermatitis Market is poised for steady expansion at a CAGR of 6.3%, valued at USD 488.1 million in 2024 and projected to hit USD 746.2 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Soft Tissue Sarcoma Treatment Market By Treatment Type (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy); By Disease Subtype (Gastrointestinal Stromal Tumors, Liposarcoma, Leiomyosarcoma, Others); By End User (Hospitals & Specialty Cancer Centers, Academic & Research Institutes, Ambulatory & Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Soft Tissue Sarcoma Treatment Market is valued at USD 4.7 billion in 2024, and it is projected to reach USD 7.9 billion by 2030, reflecti... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Nucleic Acid Therapeutics Market By Therapy Type (Antisense Oligonucleotides, RNA Interference, mRNA Therapeutics, Aptamers, Others); By Application (Genetic Disorders, Oncology, Infectious Diseases, Neurological Disorders, Others); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nucleic Acid Therapeutics Market will expand at CAGR of 16.3%, valued at USD 6.8 billion in 2024 and projected to hit USD 16.4 billion by 2030, driven by ... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Group Life Insurance Market By Coverage Type (Basic, Supplemental, Voluntary); By End-User (Corporations, Government Entities, SMBs, Non-Profit Organizations); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Group Life Insurance Market valued at USD 940 billion in 2024 and projected to reach USD 1.45 trillion by 2030 at 5.8% CAGR, highlighting market g... Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Testicular Cancer Drugs Market By Drug Type (Platinum-Based Agents, Alkylating Agents, Immunotherapy Agents, Supportive Drugs); By Route of Administration (Intravenous, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Testicular Cancer Drugs Market is forecast to register a steady CAGR of 6.3%, reaching USD 1.85 billion by 2030 from USD 1.21 billion in 2024, supported b... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Short-Acting Insulin Market By Product Type (Insulin Aspart, Insulin Lispro, Insulin Glulisine); By Route of Administration (Subcutaneous Injection, Insulin Pumps); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Short-Acting Insulin Market was valued at USD 12.5 billion in 2024 and is projected to reach USD 18.6 billion by 2030, g... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Polymyalgia Rheumatica Treatment Market By Drug Class (Corticosteroids, Immunosuppressants, Biologics); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Polymyalgia Rheumatica Treatment Market will witness a moderate CAGR of 5.6%, valued at USD 1.32 billion in 2024 and projected to reach USD 1.84 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Hereditary Transthyretin Amyloidosis Market By Treatment Type (TTR Stabilizers, Gene Silencing Therapies, Symptomatic Treatments); By Diagnostic Method (Genetic Testing, Imaging, Biomarker Testing); By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hereditary Transthyretin Amyloidosis Market is valued at approximately USD 1.2 billion in 2024 and is expected to grow to USD 2.5 billion by 2030, representing a robust Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Mydriasis Treatment Market By Product Type (Anticholinergics, Sympathomimetics, Combination Formulations, Device-Based Mydriasis); By Application (Diagnostic Imaging, Cataract & Retinal Surgery, Emergency Eye Conditions); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Optometry Clinics, Retail Vision Chains); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mydriasis Treatment Market will witness a steady CAGR of 6.8%, valued at around $790 million in 2024, expected to reach nearly $1.18 billion by 2030, acco... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Hypoparathyroidism Treatment Market By Drug Type (Calcium Supplements, Vitamin D Analogs, Recombinant PTH Therapies); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hypoparathyroidism Treatment Market is projected to grow at a CAGR of 8.1%, valued at USD 1.14 billion in 2024 and expected to reach USD 1.82 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:176 | $ 4485

Herpes Labialis Treatment Market By Treatment Type (Oral Antivirals, Topical Antivirals, OTC Products, Vaccines); By End-User (Consumers, Healthcare Providers, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Herpes Labialis Treatment Market was valued at USD 4.5 billion in 2024, and is projected to grow at a CAGR of 6.4%, reac... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Neurotrophic Keratitis Treatment Market By Treatment Type (Artificial Tears & Lubricants, Biologics [rhNGF, Serum Drops], Amniotic Membrane Products); By Disease Stage (Stage 1, Stage 2, Stage 3); By End User (Tertiary Eye Hospitals, Private Clinics, General Hospitals, Compounding Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neurotrophic Keratitis Treatment Market is anticipated to progress at CAGR of 9.1%, increasing from USD 186.5 million in 2024 to USD 314.7 million by 2030... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Necrotising Enterocolitis Market By Product Type (Pharmaceutical Interventions, Nutritional Therapies, Diagnostic Tools, Surgical Equipment); By End User (Neonatal Intensive Care Units, Pediatric & Maternity Hospitals, Research Institutes); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Necrotising Enterocolitis ( NEC ) Market is projected to grow at a CAGR of 6.8%, increasing from an estimated USD 460 million in 2024 to ... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Palmoplantar Keratoderma Market By Type (Hereditary PPK, Acquired PPK); By Treatment (Topical Therapies, Systemic Therapies, Gene & Molecular Therapies); By End User (Specialty Dermatology Clinics, General Dermatology Practices, Retail & Online Pharmacies, Teledermatology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Palmoplantar Keratoderma ( PPK ) Market is projected to grow steadily over the next several years, reaching a valuation of $1.04 billion by 2030, up from ... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Retinitis Pigmentosa Market By Treatment Type (Gene Therapy, Stem Cell Therapy, Optogenetics & Prosthetics, Adjunct Therapies); By Route of Administration (Intraocular, Oral/Systemic, Sustained-Release Ocular Implants); By End User (Specialized Ophthalmology Centers, Academic Hospitals, General Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Retinitis Pigmentosa Market growing at 5.8% CAGR, with USD 560 million in 2024 to USD 785 million by 2030, driven by retinitis pigmentosa treatmen... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Pyoderma Gangrenosum Treatment Market By Treatment Type (Topical Treatments, Systemic Treatments, Surgical Treatments); By End User (Hospitals, Dermatology Clinics, Outpatient Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pyoderma Gangrenosum Treatment Market will witness steady growth from USD 1.2 billion in 2024 to USD 2.3 billion by 2030 at a CAGR of 10.6%, supported by ... Read More

Published Date: JAN-2026 | No Of Pages:153 | $ 4485

Pediatric Brain Tumor Market By Imaging Modality (MRI, CT, Ultrasound, Functional MRI, Low-Dose CT); By Tumor Type (Gliomas, Medulloblastomas, Neuroblastomas, Others); By End-User (Children’s Hospitals, General Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Brain Tumor Market is driven by expanding pediatric oncology diagnostics, brain tumor screening technologies, neuroimaging diagnostics, ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Thymic Carcinoma Drugs Market By Drug Class (Chemotherapy Agents, Targeted Therapies, Immunotherapy); By Route of Administration (Intravenous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online & Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thymic Carcinoma Drugs Market will witness a steady CAGR of 6.4%, valued at $238.5 million in 2024, expected to appreciate and reach $366.2 million by 2030,Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Optic Neuritis Treatment Market By Treatment Type (Corticosteroids, Immunomodulators & Disease-Modifying Therapies, Monoclonal Antibodies, Plasma Exchange & Others); By Indication (MS-Associated Optic Neuritis, NMOSD, Infectious & Other Autoimmune Causes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Specialty & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Optic Neuritis Treatment Market is witnessing growth at CAGR of 8.1%, expanding from USD 1.7 billion in 2024 to USD 2.9 billion by 2030, propelled by Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Multiple System Atrophy Market By Treatment Type (Symptomatic Therapies, Disease-Modifying Pipeline, Supportive Devices); By Diagnosis (Imaging, Fluid Biomarkers, Clinical Assessment); By End User (Hospitals, Neurology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Multiple System Atrophy Market is forecast to register a CAGR of 8.6%, valued at USD 380 million in 2024 and reaching USD 625 million by 2030, driven by <... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Refractory Epilepsy Treatment Market By Treatment Type (Anti-Epileptic Drugs, Vagus Nerve Stimulation, Responsive Neurostimulation, Deep Brain Stimulation, Surgical Resection, Dietary Therapies); By Route of Administration (Oral, Injectable, Implanted Devices); By End User (Hospitals, Neurology Clinics, Pediatric Epilepsy Centers, Ambulatory Surgery Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Refractory Epilepsy Treatment Market is projected to grow at a robust CAGR of 6.9%, valued at USD 6.7 billion in 2024 and expected to surpass USD 10.1 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:177 | $ 4485

NAMPT Inhibitors Market By Molecule Type (FK866, CHS828, OT-82, KPT-9274, Others); By Indication (Hematologic Malignancies, Solid Tumors, Inflammatory Disorders); By End User (Academic & Research Institutes, CROs, Biotech Companies, Hospitals, Oncology Centers); By Region, Segment Revenue Estimation & Forecast, 2024–2030

Introduction And Strategic Context

The Global NAMPT Inhibitors Market is gaining traction as a promising frontier in targeted oncology and metabolic therapy. Valued at USD 312 million in 2024 and projected to reach around USD ... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Post Bariatric Hypoglycemia Market By Treatment Type (Pharmacologic, Nutritional, Surgical Revision, Device-Assisted Monitoring); By Patient Profile (Early Onset PBH, Late Onset PBH, Refractory PBH, Asymptomatic PBH); By End User (Bariatric Surgery Centers, Endocrinology Clinics, Digital Therapeutics Platforms, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Post Bariatric Hypoglycemia Market valued at USD 1.1 billion in 2024 and expected to reach USD 1.6 billion by 2030 at CAGR of 6.8%, propelled by h... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Hyperuricemia Market By Drug Class (Xanthine Oxidase Inhibitors, Uricosuric Agents, Uricase-Based Biologics, Combination Therapies); By Type (Asymptomatic Hyperuricemia, Symptomatic Hyperuricemia); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Channels); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyperuricemia Market is projected to grow from USD 5.8 billion in 2024 to USD 8.3 billion by 2030, registering a CAGR of 6.1%, driven by rising gout preva... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Ocular Hypertension Market By Product Type (Pharmaceuticals, Medical Devices, Surgical & Minimally Invasive Options); By Drug Class (Prostaglandin Analogs, Beta-Blockers, Carbonic Anhydrase Inhibitors, Alpha Agonists, Novel Classes); By End User (Hospital Ophthalmology Departments, Specialty Eye Clinics, Community Optometrists & Retail Pharmacies, Teleophthalmology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ocular Hypertension Market is projected to grow at a CAGR of 5.9%, from USD 5.1 billion in 2024 to USD 7.2 billion by 2030, driven by advancements in diag... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Inflammatory Myopathy Market By Type (Polymyositis, Dermatomyositis, Inclusion Body Myositis, Necrotizing Autoimmune Myopathy, Others); By Treatment (Corticosteroids, Immunosuppressants, Intravenous Immunoglobulin (IVIG), Biologics, Others); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Home Infusion Providers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inflammatory Myopathy Market valued at USD 1.65 billion in 2024 and projected to reach USD 2.4 billion by 2030 at 6.4% CAGR, reflecting market gro... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Refractory Angina Treatment Market By Treatment Type (EECP, Coronary Sinus Reducers, Spinal Cord Stimulation, Transmyocardial Laser Revascularization, Cell & Gene Therapy, Pharmacologic Agents); By Mechanism of Action (Neuromodulation, Vascular Modulation, Hemodynamic Therapy, Regenerative Therapy, Metabolic Modulation); By End User (Tertiary Care Hospitals, Cardiology Specialty Clinics, Pain Management Centers, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Refractory Angina Treatment Market will witness a steady CAGR of 6.2%, valued at USD 1.6 billion in 2024 and projected to reach USD 2.3 billion by 2030, a... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Pertussis Treatment Market By Treatment Type (Macrolides, Sulfonamides, Combination Therapies, Vaccines); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospitals, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pertussis Treatment Market is projected to grow from USD 3.2 billion in 2024 to USD 4.9 billion by 2030 at a 7.3% CAGR, driven by rising vaccination programs, antibiotic therapies, and ped... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Paraganglioma Treatment Market by Treatment Type (Surgical Treatment, Radiotherapy, Pharmacological Treatment); By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes, Ambulatory Surgical Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Paraganglioma Treatment Market valued at USD 1.2 billion in 2024 and forecast to reach USD 1.8 billion by 2030 at 5.3% CAGR, fueled by therapeutic... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Tonic-Clonic Seizure Market By Drug Class (Traditional AEDs, New-generation AEDs); By Route of Administration (Oral, Intravenous, Intranasal, Rectal); By Age Group (Pediatric, Adult, Geriatric); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tonic- Clonic Seizure Market will witness growth at CAGR of 5.8%, climbing from USD 1.87 billion in 2024 to USD 2.62 billion by 2030, supported by Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Transverse Myelitis Market By Treatment Approach (Corticosteroids, Plasma Exchange, IVIG, Immunosuppressants, Biologics); By Route of Administration (Intravenous, Oral, Subcutaneous); By End User (Hospitals, Specialty Clinics, Home Care, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transverse Myelitis Market will witness a robust CAGR of 6.5%, valued at $654 million in 2024, expected to appreciate and reach $961 million by 2030, acco... Read More

Published Date: JAN-2026 | No Of Pages:152 | $ 4485